Article
Understanding the MIG6-EGFR Signaling Axis in Lung Tumorigenesis.
Cancer discovery - 1 May 2015
Izumchenko Evgeny, Sidransky David
Abstract excerpt
With multiple clinical trials under way targeting mutant EGFR in patients with lung cancer, Maity and colleagues address important aspects of a MIG6-EGFR signaling axis using genetically engineered mouse models expressing mutated EGFRs on the MIG6-deficient background. This study extends our understanding of EGFR regulation by MIG6 and reveals that MIG6 antagonizes tumor formation in mutant EGFR-driven lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
